Video is available - Log in to view. You must be registered to the event to view content
Organized by Eurofins Transplant Genomics
At this event, we will be hosting John Friedewald, MD, FAST, FASN from Northwestern University’s Comprehensive Transplant Center as he discusses non-invasive genetic biomarkers. These biomarkers offer transplant teams a clinically-valid alternative to surveillance biopsies for detecting incipient rejection. This presentation will explore the use of a novel panel of complementary biomarkers (the OmniGraf™ rejection biomarker panel, from Eurofins Transplant Diagnostics) through a discussion of several case studies where biomarker guidance informed intervention and improved outcomes.
